West Pharmaceutical Services Aktie
| 282,13USD | 3,60USD | 1,29% |
WKN: 864330 / ISIN: US9553061055
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 9 200 | 10 065 | 10 700 | 10 600 | 10 600 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,23 | 0,28 | 0,27 | 0,28 | 0,27 |
Bilanz (in Mio. USD) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 1 374 | 1 742 | 1 920 | 1 936 | 1 538 |
| Summe Anlagevermögen | 1 420 | 1 572 | 1 697 | 1 893 | 2 105 |
| Summe Aktiva | 2 794 | 3 314 | 3 617 | 3 830 | 3 643 |
Bilanz (in Mio. USD) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 939 | 978 | 932 | 949 | 961 |
| Summe Eigenkapital | 1 855 | 2 335 | 2 685 | 2 881 | 2 682 |
| Summe Passiva | 2 794 | 3 314 | 3 617 | 3 830 | 3 643 |
Adresse
| 530 Herman O. West Drive, 19341-1147 Exton | |
| Telefon | +1 (610) 594-2900 |
| Internet | http://www.westpharma.com |
Management
|
Annette F. Favorite
Chief Human Resources Officer & Senior VP |
|
Chad R. Winters
Chief Accounting Officer & VP-Finance |
|
Deborah L. V. Keller
Independent Director |
|
Donald A. McMillan
Vice President-Enterprise Business Systems |
|
Douglas A. Michels
Independent Director |
|
Eric Mark Green
Chairman, President & Chief Executive Officer |
|
Janet Brutschea Haugen
Independent Director |
|
Kathy dePadua
Chief Quality & Regulatory Officer, Senior VP |
|
Kimberly Banks MacKay
Secretary, Senior Vice President & General Counsel |
|
Mark A. Buthman
Independent Director |
|
Molly E. Joseph
Independent Director |
|
Myla P. Lai-Goldman
Independent Director |
|
Paolo Pucci
Lead Independent Director |
|
Quintin John Lai
Vice President-Corporate Development & Strategy |
|
Robert F. Friel
Independent Director |
|
Robert W. McMahon
Chief Financial Officer & Senior Vice President |
|
Rudy Poussot
Senior VP-Strategy & Corporate Development |
|
Shane Campbell
Chief Proprietary Segment Officer & Senior VP |
|
Stephen H. Lockhart
Independent Director |
|
Thomas W. Hofmann
Independent Director |
|
William F. Feehery
Independent Director |